News
The tender evaluation committee of the State Department for Housing and Urban Development had recommended Keddy Enterprises ...
The future of San Francisco’s Mexican Museum is in jeopardy after the beleaguered organization missed a key fundraising deadline for the construction of its long-gestating downtown location. The ...
NAPOLI 3, a phase 3 study of NALIRIFOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Final overall survival (OS) analysis and characteristics of the long-term survivors.
In a big leap for Mumbai’s public transport, Metro Line 3's second phase—connecting Bandra-Kurla Complex (BKC) to Acharya Atre Chowk in Worli—officially began operations on Saturday ...
Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis ...
In its first global phase 3 readout, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody ivonescimab reduced the risk of progression or death by 48% in patients with ...
Pueblo West Metro Board swears in 3 new members. Board OK's Liberty Point maintenance agreement as part of upcoming Purcell Trail construction. Fire chief updates board on Fire Station No. 1 ...
Denifanstat showed positive Phase 3 results in acne, meeting all goals with strong safety, as Sagimet pushes ahead with a second FASN inhibitor trial.
Hosted on MSN28d
June 3 School Board of Alachua County meeting - MSNThe School Board of Alachua County, Florida, shall hold a public meeting to which all persons are invited. DATE AND TIME: Tuesday, June 3, 2025, at 6 p.m. LOCATION: District Office Boardroom, 620 ...
a Formal significance testing was only performed at 52 weeks in the Phase 3 trials, with significance achieved for both the every two-week arm and every four-week arm in AERIFY-1 . The total number of ...
Cartesian Therapeutics Initiates Phase 3 AURORA Trial of Descartes-08 for Myasthenia Gravis - Nasdaq
Cartesian Therapeutics enrolls first participant in Phase 3 trial of Descartes-08 for myasthenia gravis treatment. Quiver AI Summary. Cartesian Therapeutics, Inc. has announced the enrollment of ...
Yvonne Odoley Sowah, who served on the GIIF Board from 2017 to 2021, explicitly declared in her statement dated May 28, 2025, that during her time, former CEO Solomon Asamoah "did not submit any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results